These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 30646507)

  • 1. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
    Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D, Epstein-Barr virus, and endogenous retroviruses in multiple sclerosis - facts and hypotheses.
    Brütting C; Stangl GI; Staege MS
    J Integr Neurosci; 2021 Mar; 20(1):233-238. PubMed ID: 33834708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms.
    O'Gorman C; Lucas R; Taylor B
    Int J Mol Sci; 2012; 13(9):11718-11752. PubMed ID: 23109880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J
    J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.
    Keane JT; Afrasiabi A; Schibeci SD; Fewings N; Parnell GP; Swaminathan S; Booth DR
    Front Immunol; 2021; 12():732694. PubMed ID: 34566997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology of multiple sclerosis.
    Pender MP; Greer JM
    Curr Allergy Asthma Rep; 2007 Jul; 7(4):285-92. PubMed ID: 17547851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis.
    Hassani A; Reguraman N; Shehab S; Khan G
    Front Immunol; 2021; 12():764937. PubMed ID: 34899715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
    Owens GP; Bennett JL
    Mult Scler; 2012 Sep; 18(9):1204-8. PubMed ID: 22685062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus genotypes in multiple sclerosis.
    Lindsey JW; Patel S; Zou J
    Acta Neurol Scand; 2008 Feb; 117(2):141-4. PubMed ID: 18184350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
    Brennan RM; Burrows JM; Bell MJ; Bromham L; Csurhes PA; Lenarczyk A; Sverndal J; Klintenstedt J; Pender MP; Burrows SR
    Mult Scler; 2010 Jun; 16(6):643-51. PubMed ID: 20350958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
    Sargsyan SA; Shearer AJ; Ritchie AM; Burgoon MP; Anderson S; Hemmer B; Stadelmann C; Gattenlöhner S; Owens GP; Gilden D; Bennett JL
    Neurology; 2010 Apr; 74(14):1127-35. PubMed ID: 20220124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of human endogenous retroviruses (HERVs) in Multiple Sclerosis and the plausible interplay between HERVs, Epstein-Barr virus infection, and vitamin D.
    Latifi T; Zebardast A; Marashi SM
    Mult Scler Relat Disord; 2022 Jan; 57():103318. PubMed ID: 35158423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis.
    Laurence M; Benito-León J
    Mult Scler Relat Disord; 2017 Aug; 16():8-14. PubMed ID: 28755684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MULTIPLE SCLEROSIS - RISK FACTORS.
    Adamczyk-Sowa M; Gębka-Kępińska B; Kępiński M
    Wiad Lek; 2020; 73(12 cz 1):2677-2682. PubMed ID: 33577489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
    Serafini B; Rosicarelli B; Franciotta D; Magliozzi R; Reynolds R; Cinque P; Andreoni L; Trivedi P; Salvetti M; Faggioni A; Aloisi F
    J Exp Med; 2007 Nov; 204(12):2899-912. PubMed ID: 17984305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DRB1*15:01 is a co-receptor for Epstein-Barr virus, linking genetic and environmental risk factors for multiple sclerosis.
    Menegatti J; Schub D; Schäfer M; Grässer FA; Ruprecht K
    Eur J Immunol; 2021 Sep; 51(9):2348-2350. PubMed ID: 34019695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translational Mini-Review Series on B cell subsets in disease. B cells in multiple sclerosis: drivers of disease pathogenesis and Trojan horse for Epstein-Barr virus entry to the central nervous system?
    Meier UC; Giovannoni G; Tzartos JS; Khan G
    Clin Exp Immunol; 2012 Jan; 167(1):1-6. PubMed ID: 22132878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.